363 related articles for article (PubMed ID: 24976142)
1. Prevalence and circulation patterns of variant, atypical and resistant HIV in Los Angeles County (2007-2009).
Sey K; Ma Y; Lan YC; Song N; Hu YW; Ou Y; Frye D
J Med Virol; 2014 Oct; 86(10):1639-47. PubMed ID: 24976142
[TBL] [Abstract][Full Text] [Related]
2. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.
Zhang J; Guo Z; Yang J; Pan X; Jiang J; Ding X; Zhang W; Xia Y; Xu Y; Huang J
J Med Virol; 2015 Oct; 87(10):1668-76. PubMed ID: 25899877
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
[TBL] [Abstract][Full Text] [Related]
6. Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy.
Riva C; Lai A; Caramma I; Corvasce S; Violin M; Dehò L; Prati F; Rossi C; Colombo MC; Capetti A; Franzetti M; Rossini V; Tambussi G; Ciccozzi M; Suligoi B; Mussini C; Rezza G; Balotta C
AIDS Res Hum Retroviruses; 2010 Jan; 26(1):41-9. PubMed ID: 20055587
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
Liu J; Yue J; Wu S; Yan Y
Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
[TBL] [Abstract][Full Text] [Related]
8. Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.
Alexiev I; Shankar A; Wensing AM; Beshkov D; Elenkov I; Stoycheva M; Nikolova D; Nikolova M; Switzer WM
J Antimicrob Chemother; 2015; 70(6):1874-80. PubMed ID: 25652746
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of drug-resistant HIV type 1 at the time of initiation of antiretroviral therapy in Portland, Oregon.
MacVeigh MS; Kosmetatos MK; McDonald JE; Reeder JL; Parrish DA; Young TP
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):337-42. PubMed ID: 22697610
[TBL] [Abstract][Full Text] [Related]
10. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.
Skoura L; Metallidis S; Buckton AJ; Mbisa JL; Pilalas D; Papadimitriou E; Papoutsi A; Haidich AB; Chrysanthidis T; Tsachouridou O; Antoniadou ZA; Kollaras P; Nikolaidis P; Malisiovas N
J Antimicrob Chemother; 2011 Dec; 66(12):2831-7. PubMed ID: 21933785
[TBL] [Abstract][Full Text] [Related]
11. Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008.
Stańczak GP; Stańczak JJ; Marczyńska M; Firlag-Burkacka E; Wiercińska-Drapało A; Leszczyszyn-Pynka M; Jabłonowska E; Małolepsza E; Dyda T; Zabek P; Horban A
J Med Virol; 2010 Jul; 82(7):1291-4. PubMed ID: 20513098
[TBL] [Abstract][Full Text] [Related]
12. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
Ferreira AS; Cardoso LP; Stefani MM
J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
[TBL] [Abstract][Full Text] [Related]
13. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M
PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals.
Vahabpour R; Bokharaei-Salim F; Kalantari S; Garshasbi S; Monavari SH; Esghaei M; Memarnejadian A; Fakhim A; Keyvani H
Arch Virol; 2017 Jun; 162(6):1477-1485. PubMed ID: 28181034
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
Balode D; Westman M; Kolupajeva T; Rozentale B; Albert J
J Med Virol; 2010 Dec; 82(12):2013-8. PubMed ID: 20981787
[TBL] [Abstract][Full Text] [Related]
17. Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).
Ambrosioni J; Sued O; Nicolas D; Parera M; López-Diéguez M; Romero A; Agüero F; Marcos MÁ; Manzardo C; Zamora L; Gómez-Carrillo M; Gatell JM; Pumarola T; Miró JM
PLoS One; 2015; 10(6):e0125837. PubMed ID: 26039689
[TBL] [Abstract][Full Text] [Related]
18. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
[TBL] [Abstract][Full Text] [Related]
19. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
20. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
